Vir Biotech, GSK Revise Agreement for Coronavirus Treatments
Image Source:- >> | Content Source:- >>
Vir Biotechnology—a San Francisco-based commercial-stage immunology company—stated that their research collaboration agreement with GSK in 2020 has been modified. This modification reflects the fact that Vir will continue its ongoing efforts to discover, innovate, and advance next-generation treatments for COVID-19 and other potential coronavirus outbreaks, either alone or in collaboration. In addition to exploring innovative therapies for influenza and other respiratory illnesses, the companies will continue to ensure that drugs like sotrovimab should be globally accessible.
By the provisions of the newly modified contract, Vir will continue to have exclusive rights to advance next-generation products resulting from the collaborative coronavirus vaccine and antibody initiatives in exchange for tiered low-to mid-single-digit royalties to GSK.
About Ingenious e-Brain:-
Ingenious e-Brain provides high-quality, customized, and cost-effective Technology Research, Business Research, and Intellectual Property Research solutions to industry leaders and innovative companies across the globe. Innovation, knowledge, and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide the highest quality results ensuring fool-proof confidentiality and security. We are an ISO-certified company with offices in India and USA.
Ingenious e-Brain has a strong team of analysts and subject matter experts with domain proficiency which is devoted to helping clients grow. Our highly qualified professionals offer tailored, value-added, and cost-effective services to our clients. We believe in building long-term relationships with our clients which include national and international corporations, Fortune 500 companies, the world’s leading research institutes and universities as well as independent inventors.
Get in Touch:-
India Office
207-208 Welldone TechPark, Sohna Road
Sector 48, Gurugram, Haryana 122018, India
+91 124 429 4218
Email:-
contact@iebrain.com